Incidence and Risk Factor of Post-ERCP Pancreatitis in Chronic Pancreatitis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

2028 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-01-31

Study Completion Date

2015-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare the incidence of post-ERCP pancreatitis (PEP) in chronic pancreatitis (CP) patients to that in biliary disease patients, to determine whether CP patients in early clinical stage have a higher PEP incidence, and to identify the predictive and protective factors for PEP in chronic pancreatitis patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Natural Course and Therapeutic Effect of Chronic Pancreatitis

NCT06925204

Chronic Pancreatitis

RECRUITING

The Association Between Post-ERCP Acute Pancreatitis and Various Genetic Mutations

NCT02928718

Acute Pancreatitis

COMPLETED

Relationship of CP and AP

NCT04670705

Chronic Pancreatitis Acute Pancreatitis

COMPLETED

Establishment and Verification of Pancreatic Volume Formula Based on Imaging

NCT05410795

Healthy People Chronic Pancreatitis Acute Pancreatitis

UNKNOWN

Fatigue, Psychological Comorbidity and Quality of Life Among Patients With Chronic Pancreatitis in China.

NCT05489003

Chronic Pancreatitis

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Analysis of patients with chronic pancreatitis (CP group) and biliary disease (BD group) in Changhai Hospital from January 2011 to May 2015 were conducted. Difference of PEP incidences between BD group and CP group, as well as between M-ANNHEIM subcategories were calculated by chi-square test or Fisher's exact test. The predictive and protective factors for PEP were investigated by univariate and multivariate analysis.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Post-ERCP Acute Pancreatitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CP group

Those patients with chronic pancreatitis underwent ERCP for pancreatic stone clearance, pancreatic stent placement, etc..

chronic pancreatitis

Intervention Type OTHER

patients with chronic pancreatitis

BD group

Those patients with biliary ductal disease, such as choledocholithiasis, underwent ERCP to relieve outflow obstruction of the common bile duct.

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

chronic pancreatitis

patients with chronic pancreatitis

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients with an endoscope inserted to cannulate the pancreatic/biliary duct were included.

Exclusion Criteria

* patients in whom the papilla of Vater was not reached;
* patients who underwent stent removal procedures without ductal cannulation;
* patients in whom the intubation was failed.

Minimum Eligible Age

5 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No